I Abstract I Introduction
Prenylamine (R,S-N-(3,3-diphenylpropyl-methyl-2. phenethylamine), a World Health Organization class V calcium antagonist, is known to be metabolized to amphetamine. In this study, amphetamine concentrations after a single-dose administration of prenylamine were determined to check if they reached values that could be of analytical and/or pharmacological importance in clinical and forensic toxicology. Enantiomeric composition of amphetamine was also studied. Five volunteers received a single 120-mg oral dose of prenylamine. Urine samples were analyzed using the Abbott TDx immunoassay Amphetamine/Methamphetamine II and using our routine systematic toxicological analysis (STA) gas chromatography-mass spectrometry (GC-MS) procedure. For quantitation purposes, GC-MS was used in the selected-ion monitoring (SIM) mode (ions m/z 118, 122, 240, 244) after solid-phase extraction (Isolute Confirm HCX) and derivatization (heptafluorobutyric anhydride). Amphetamine-ds was used as internal standard (IS). Chiral separation of the heptafluorobutyrated amphetamine enantiomers was achieved using an Astec Chiraldex G-PN column. The TDx results showed a great variability for the different volunteers. A urine sample of one volunteer showed results as high as 3200 ng/mL, whereas the urine samples of another volunteer never gave results greater than the TDx detection limit (100 ng/mL). Using the STA procedure, the presence of amphetamine could be confirmed in all urine samples with TDx results greater than the cutoff value (300 ng/mL). Using the GC-MS SIM method, amphetamine concentrations up to 1280 ng/mL were determined. Chiral analysis revealed that both enantiomers of amphetamine were present in the samples with a surplus of the S(+)-enantiomer in the early phase of excretion. Forensic implications are discussed. ' Results were reported in part at the 38th TIAFT meeting, Helsinki, Finland, August 13-17, 2000. t Author to whom correspondence should be addressed.
Prenylamine (R~-N-(3,3-diphenylpropyl-methyl-2-phenethylamine, Segontin | Figure 1 ) was, besides verapamil, the first substance introduced as a calcium antagonist. This class of medicaments mimicked the cardiac effects of simple Ca 2+ withdrawal in that they diminished Ca2+-dependent high energy phosphate utilization, contractile force, and oxygen requirement of the beating heart without impairing the Na*-dependent action potential parameters (1) . Prenylamine has widely been used as antianginal drug (2) . However, its use has decreased since reports of severe side effects like episodes of ventricular tachycardia of the "torsade de pointes" type appeared (3, 4) . Nevertheless, it is still in use in several countries (e.g., in several Eastern Europe countries and Asia). Prenylamine is known to be metabolized to amphetamine, but only to a minor extent (5) . N-Dealkylation of prenylamine mainly leads to 3,3-diphenyl-propaneamine. In Figure 1 , prenylamine and its two N-dealkylated metabolites are shown. Analysis of a urine sample sent to our laboratory for screening purposes resulted in prenyiamine findings. Interestingly, high amphetamine levels were additionally found. Therefore, we performed a study with five volunteers to check whether this amphetamine finding could be caused by intake of prenylamine. We have studied whether the Abbott fluorescence polarization immunoassay (FPIA) showed positive results and whether confirmation of positive immunoassay results was possible using our systematic toxicological analysis (STA) procedure employing full scan gas chromatography-mass spectrometry (GC-MS) (6) (7) (8) (9) (10) . This STA procedure included acid hydrolysis for fast cleavage of conjugates, universal liquid-liquid extraction, and acetylation. It allows simultaneous identification of most of the toxicologically relevant drugs. In addition, GC-MS quantitation of amphetamine levels after solid-phase extraction (SPE) and heptafluorobutyrylation was performed, as well as elucidation of the enantiomeric composition of amphetamine. Implications for forensic interpretation are also discussed.
Experimental

Chemicals and reagents
All chemicals were of analytical grade and they were obtained from E. Merck (Darmstadt, Germany)./?-(-)-Amphetamine hydrochloride and S-(+)-amphetamine hydrochloride were obtained from Lipomed (Arlesheim, Switzerland). Isolute Confirm HCX SPE columns were purchased from ICT (Bad Homburg, Germany), and the internal standard (IS) amphetamine-ds was from Promochem (Wesel, Germany). Prenylamine was kindly supplied by the manufacturer.
Urine samples
The investigations were performed on urine samples from five volunteers (after informed consent according to the Declaration of Helsinki). Each volunteer received a single oral dose of 120 mg of prenylamine. Urine samples were collected every 4 h for 5 days and stored at -20~ until analysis. Before ingestion of prenylamine, control urine samples were given by the volunteers and checked for being drug free.
Apparalus
Fluorescence polarization irnrnunoassay (FPIA). Native urine samples from the volunteers were used for immunological determination. The TDx system of Abbott (Irving, TX) with the amphetamine/methamphetamine II (AM/MA II) assay was applied. The cutoff value and the detection limit (LOD) recommended by the manufacturer were 300 and 100 ng/mL, respectively. To determine cross-reactivity of prenylamine with the assay, blank urine samples were spiked with prenylamine in concentrations of 100-100,000 ng/mL.
GC-MS.
The extracts were analyzed using a Hewlett-Packard (HP, Waldbronn, Germany) 5890 series II GC combined with an HP 5989B MS Engine MS and an HP Chemstation series G1034C version C03.00. The achiral GC conditions were as follows: splitless injection mode; column, HP capillary (12 m • 0.2-mm i.d.), cross-linked methylsilicone, 330-nm film thickness; injection port temperature, 280~ carrier gas, helium; flow-rate I mL/min; column temperature, programmed from 100 to 310~ at 30~ initial time 3 rain, final time 8 rain. The chiral GC conditions were as follows: splitless injection mode; column, Astec Chiraldex G-PN capillary (30 m • 0.25 ram); injection port temperature, 210~ carrier gas, helium; flow-rate 1 mL/min; column temperature, programmed from 100 to 220~ at 10~ initial time 3 rain, final time 3 rain. The MS conditions were as follows: full scan mode or SIM mode; electron ionization (EI) mode: ionization energy, 70 eV; ion source temperature, 220~ and capillary direct interface heated at 260~
Methods
Sample preparation of urine for STA procedure
A 5-mL portion of urine was divided in two equal parts. One part was refluxed with i mL of 37% hydrochloric acid for 15 rain. Following hydrolysis, the sample was basified with 1.5 rnL of 10 mol/L aqueous sodium hydroxide, and the resulting solution was mixed with 2 mL of 2.3 mol/L aqueous ammonium sulfate to obtain a pH between 8 and 9. Before extraction, 2.5 mL of native urine was added. This solution was extracted with 5 mL of a dichlorornethane/isopropanol/ethyl acetate mixture (1:1:3, v/v). After phase separation by centrifugation, the organic layer was transferred and evaporated to dryness. The residue was derivatized by acetylation with 50 pL of an acetic anhydride/pyridine mixture (3:2, v/v) for 5 rain under microwave irradiation at about 400 W (9-11). After evaporation of the derivatization mixture, the residue was dissolved in 50 pL of methanol, and 2 pL was injected into the GC.
Sample preparation of urine for quantitation procedure
To a 1-mL portion of urine, 100 ng of the IS amphetamine-d5 was added. The sample was placed on the SPE column (Isolute Confirm HCX), conditioned as follows: 1 mL of methanol at a flow rate of 10 mlJmin, drying the column under vacuum for 15 s, and 1 mL of water at a flow rate of 10 rnL/min. The sample was rinsed through the sorbent at a flow rate of 3 mL/rnin. The column was washed with 1 mL of water, 1 mL of 0.01M aqueous HC1, and then with 2 mL of methanol. After drying at maximum vacuum for 5 rain, the analytes were eluted with a mixture of methanol and ammonia (98:2, v/v). The eluate was carefully evaporated to dryness at 56~ under nitrogen. The residue was dissolved in 100 IJL of ethyl acetate. Heptafluorobutyric anhydride (25 IlL) was added, and the sample was derivatized for 5 rnin at 440 W in a microwave oven. The mixture was then carefully evaporated to dryness at 56~ under nitrogen. The residue was dissolved in 50 IJL of ethyl acetate, and an 1-1JL aliquot of this extract was injected into the GC-MS.
GC-MS procedure for STA
During GC separation, full EI mass spectra were recorded and stored. In order to confirm the presence of amphetamine, mass chromatography was used with the ions rn/z 86 and 118 for screening. These ions were selected from the mass spectra of our reference library (12, 13) . Generation of the mass chromatograms could be started by clicking the corresponding pull-down menu that executes the user-defined macros (7) . The identity of the peaks in the mass chromatograms was confirmed by computerized comparison of the peaks underlying full mass spectra with reference spectra (12, 13) .
GC-MS procedure for quantitation
For quantitation purposes, SIM mode was used with the ions mlz 118 and 240 for heptafluorobutyrated amphetamine and mlz 122 and 244 for the heptafluorobutyrated IS amphetamineds. MS was switched on between 4 min and 7 min for the achiral procedure and between 8 min and 12 rain for the chiral procedure. Amphetamine was quantitated by comparison of the peak-area ratio of fragment ion mlz 240 versus that of ion mlz 244 for the IS with the calibration curve in which the peak-area ratios of the standards were plotted versus their concentrations. For the chiral procedure the corresponding ratio of ion mlz 118 versus mlz 122 was used because of a small interference peak for mlz 240 between the enantiomer peaks.
Results and Discussion
The aim of this study was to determine if single-dose administration of prenylamine could lead to positive amphetamine findings in urine. Immunoassay prescreening procedures were checked as well as full-scan GC-MS confirmation in the bounds of our STA procedure. In addition, GC-MS quantitation of amphetamine levels was performed as well as elucidation of the enantiomeric composition of amphetamine.
Immunoassay results
The blank urine samples that were spiked with prenylamine showed no positive results with the FPIA even at the highest concentration tested (100,000 ng/mL). This indicates that the positive results of the urine samples from the volunteers should be caused by metabolites, probably by amphetamine. In Table I , the immunoassay results of the urine samples of the five volunteers are shown. As can be seen, only two of the five volunteers showed results over the cutoff value recommended by the manufacturer (300 ng/mL). Volunteer 2 (V2) reached a maximum value of 400 ng/mL in the 20-h sample, whereas volunteer 5 (V5) had a maximum value of 3200 ng/mL in the 8-h sample. The longest time after ingestion at which values above the cutoff could be measured was 24 h (V2). It should be noted that these relatively low amphetamine results were caused by a single-dose ingestion of prenylamine. A patient under long-term therapy with prenylamine may exhibit higher amphetamine results. As a result of this study, it must be stated, that intake of prenylamine did lead to positive amphetamine immunoassay results that must be confirmed by a second independent method. In our laboratory, such confirmation can be achieved as part of our STA procedure.
Confirmation of positive immunoassay results in urine using the STA procedure
The extraction solvent used has proven to be very efficient for an STA procedure (7,9,10,12-15). The use of microwave irradiation for acetylation reduced the incubation time from 30 min to 5 min (9-11), so that derivatization should no longer be renounced because of time consumption. The STA procedure has also proven to be suitable for confirmation of positive immunoassay results for amphetamine (16) (17) (18) (19) . All the urine samples that were tested positive with the FPIA (cutoff 300 ng/mL) could be confirmed by the STA procedure. It should be noted, that this procedure is not specifically designed as a confirmation method for positive immunoassay prescreening results, but is usually used for screening purposes in clinical and forensic toxicology. It is suitable for simultaneous detection of a great variety of drugs, poisons, and their metabolites (6, 12, 13, 20) and for confirmation and differentiation of amphetamines (16) (17) (18) (19) and many other drugs of abuse (12) (13) (14) (21) (22) (23) (24) (25) (26) .
Quantitation of amphetamine in urine
As described, the used confirmation procedure is not especially designed for amphetamine analysis. For determination of single analytes, SPE and the use of deuterated internal standards is recommended. The described SPE led to very clean extracts with extraction yields of 80-90%. Evaporation of the eluate at moderate temperature (56~ prevented substantial losses of analytes during evaporation. Heptafluorobutyrylation instead of acetylation led to sharper GC peaks and higher sensitivity. Use of deuterated IS allowed precise quantitation and compensated for possible batch-to-batch inconformity of SPE columns. The LOD of the GC-MS procedure was 5 ng/mL. Limit of quantitation (LOQ) was 10 ng/mL. The method was linear from 10 ng/mL up to 500 ng/mL with accuracy and within-run and between-run precision well within required limits (27, 28) . Urine samples with higher amphetamine concentrations were correspondingly diluted with blank urine before extraction.
Amphetamine levels were determined in all urine samples of the five volunteers. Table II shows the amphetamine concentrations in the urine samples of the volunteers I-5. Figure 2 shows corresponding mass fragmentograms indicating 114.8 nglmL of amphetamine. Amphetamine concentration determined by GC-MS in the urine sample with the highest TDx value (3200 ng/mL) was 1280 ng/mL. The differences between the immunoassay and the GC-MS results may be due to the well-known different cmss-reactivities at different concentration ]evels and/or due to other amphetamine metabolites. Because of the high sensitivity of the method, amphetamine could be detected in urine samples for up to 96 h. These results showed a great interindividual variability in the pharmacokinetics of prenylamine, which is in accordance to the literature (29) . Nevertheless, important urine parameters (pH value, creatinine concentration) were monitored, because it is well known, that they can influence amphetamine concentrations. Urinary excretion of amphetamines is markedly influenced by pH in the kidney ultrafiltrate. Indeed, the urine sample with the highest amphetamine concentration had a slightly acidic pH of 5.5. In addition, creatinine was somewhat high (350 mgldL). However, urine samples from other volunteers that had similar pH values and high creatinine values were negative for amphetamine. Therefore, it can be concluded that parameters other than these might be responsible for the great interindividual differences between the volunteers. Involvement of different cytochrome P450 isoenzymes in the N-dealkylation of prenylamine to amphetamine could explain the differences.
Enantiomeric composition of the prenylamine metabolite amphetamine in urine
Using the Chiraldex G-PN column under the described conditions, separation of the amphetamine enantiomers was achieved in less than 11 min using the heptafluorobutyrated extracts that were used for quantitation of amphetamine. For quantification of the enantiomers, MS was performed in the SIM mode. The method was linear from 10 to 250 ng/mL per enantiomer with accuracy and within-run and between-run precision well within required limits (27, 28) . Urine samples with higher amphetamine concentrations were correspondingly diluted with blank urine before extraction. Figure 3 shows corresponding mass fragmentograms of a heptafluorobutyrated extract of a urine sample after ingestion of 120 mg of prenylamine. As shown in Figure 4 , the enantiomer ratio of amphetamine changes with time. In the early phase of excretion (up to 12-24 h) after a single dose application, the S(+) enantiomer is excreted into urine in higher amounts than the R(-) enantiomer. In a later phase of excretion, the R(-) enantiomer can be measured in excess of the S(+). plasma than R-(-)-prenylamine suggesting a stereoselective metabolism. In another study on prenylamine, Gietl et al. (30) showed that the maximum plasma concentrations and area under the curves of the R(-) enantiomer exceeded those of the S(+) enantiomer fivefold. The apparent oral clearance of the Sform was five times and the renal clearance three times higher than that of the R-form. Plasma protein binding also differed between the two enantiomers, generally with a higher unbound fraction of the S-form (30). All these findings concerning the parent compound showed that the S(+) enantiomer of prenylamine disappeared faster from the plasma than its antipode and help in understanding the surplus of the S-enantiomer of the amphetamine metabolite in urine. There are no hints in the literature whether Ar-dealkylation of prenylamine prefers the Senantiomer, thus leading to a surplus of the corresponding Senantiomer of amphetamine in the early phase of excretion. Therefore, we are currently studying the cytochrome P450 dependent enantioselective metabolism of prenylamine. The results of these studies will be published elsewhere.
Forensic implications
It can be stated that even single-dose ingestion of prenylamine may lead to positive amphetamine findings in immunoassay screening as well as in GC-MS screening. As already criticized in former publications (16,17,19,31) , confirmation of positive immunoassay results for amphetamines should not be limited to detection of amphetamine (and methamphetamine) by GC-MS in the SIM mode (unless the testing program forbids analysis of analytes not specifically part of the testing program). The full-scan mode has some advantages for confirmation analysis. In the case of prenylamine, specific prenylamine metabolites could additionally be detected in all amphetamine positive urine samples using our full-scan GC-MS procedure for systematic toxicological analysis. The parent compound prenylamine could not be detected in all amphetamine-positive samples, whereas the main metabolite 3,3-diphenyl-propaneamine (Figure 1 ) was present in all these samples. Therefore, detection of amphetamine without detection of at least that metabolite cannot be caused by legal intake of prenylamine. However, detection of the main metabolite of prenylamine in addition to amphetamine does not automatically exclude intake of illicit amphetamine additionally to prenylamine. Additional data like analyte ratios might be helpful in these cases.
Conclusions
It can be stated that intake of prenylamine may lead to positive amphetamine results in urine drug testing. However, a great interindividual variability could be observed. Some individuals seem not to produce amphetamine from prenylamine, wheras others easily reached values even over 1000 ng/mL. Chiral analysis revealed that both enantiomers of amphetamine were present in the samples, with a surplus of the S(+) enantiomer up to 12-24 h after single dose ingestion. Differentiation of prenylamine intake from illicit amphetamine use may be possible by detection of specific prenylamine metabolites.
